Training practice for professionals in hospital infection prevention and control in Jiangsu Province under the background of medical and prevention integration / 中华医院管理杂志

The prevention and control of hospital infections(hereinafter referred to as infection control) is key to the implementation of " medical and prevention integration" in medical institutions. And the professional knowledge and skill level of infection control professionals is one of the critical factors directly affecting the infection control capacity of these institutions. Jiangsu Province has been exploring to establish a job training system for newly recruited full-time infection control staff since 2021 based on their core competency needs. In January 2022, the new training system was put into use. The province formulated a training outline for new full-time infection control personnel, established a provincial-level infection control trainers pool through training and competitive selection, and then selected the best ones for provincial infection control full-time personnel training bases. Then the province organized job training covering both theoretical learning and practical aspects, and examined their corresponding theoretical knowledge and practical operation. Theoretical learning was made via online courses; Practical training was made at designated tertiary hospitals, covering clinical practice in key departments, environmental hygiene monitoring, hospital infection case monitoring, and application of infection control information systems. Among 804 new full-time personnel trained in 2022, 567 passed the graduation examination at a pass rate of 70.52%. The job training system for new full-time infection control personnel built in Jiangsu Province proves useful for the management of job training for such personnel in other provinces.

Clinical characteristics and risk factors for mortality of patients with severe fever with thrombocytopenia syndrome / 中华传染病杂志

Objective To summarize the clinical and laboratory characteristics of patients with severe fever with thrombocytopenia syndrome (SFTS ) and to identify the related risk factors for mortality .Methods Clinical features and laboratory parameters were collected from 40 SFTS patients (7 deaths and 33 survivors) .Dynamic changes of laboratory data were compared between the two groups , including white blood cell count (WBC ) , platelet count (PLT ) , alanine aminotransferase (ALT ) , aspartate aminotransferase (AST) ,creatine kinase (CK) ,lactate dehydrogenase (LDH) ,prothrombin time (PT) ,activated partial thromboplastin time (APTT) and thrombin time (TT) .Continuous variables with normal distribution were compared with t test ,and those with non‐normal distribution were compared with nonparametric test ;categorical variables were compared with χ2 test .Univariate Logistic regression was used to evaluate the risk factors associated with death .Results For the deceased patients and the survivors ,the APTT were 56 .40 s and 44 .45 s ,respectively (Z=5 .419 ,P=0 .04) at day 1—7 .Those were 66 .25 s and 36 .85 s ,respectively (Z=10 .112 ,P=0 .009) at day 8—10 ,and (125 .06 ± 11 .88) s and (33 .44 ± 6 .50) s ,respectively (t=45 .760 ,P 15 s (OR= 24 .00 ,95% CI:1 .99—289 .60) ,APTT>70 s (OR= 42 .67 ,95% CI:3 .54—514 .85) and TT > 120 s (OR= 0 .14 ,95% CI:0 .02—0 .88) were risk factors for the death of SFTS patients (all P< 0 .05) .Conclusion Prolonged APT T ,T T and PT at early stage and progressively increasing during the disease course suggest poor prognosis of SFTS .

Construction and screening of human immunodeficiency virus-1 negative regulation factor peptide-specific CD4+T lymphocyte clone / 中华传染病杂志

Objective To construct and screen the human immunodeficiency virus-1 (HIV-1) negative regulation factor (Nef) peptide-specific CD4+ T lymphocyte clone.Methods Peripheral blood mononuclear cells (PBMC) from five asymptomatic HIV-1 infected patients were collected and Bulkcultured with Nef end peptides.The CD4 molecule and intracellular interferon (IFN)-gamma of cultured cells were detected by two-color flow cytometry.The Nef end peptide-specific T cell clone was then constructed by limited dilution and confirmed through enzyme linked immunospot assay (ELISPOT).The best grown cells were selected and cultured as the final clone.Results The Nef end peptide-specific-T lymphocyte clone was successfully constructed from PBMC of one HIV-infected patient and confirmed by ELISPOT.The detection of human leukocyte antigen (HLA)-DRB1 type showed that the epitope of this peptide was probably HLA-DRB1 * 0406.Conclusion The Nef end specific-T cell clone is successfully constructed,and a new epitope in the C-terminus of Nef protein and its HLA restriction are identified.